News — Healthcare & Biotech

Sector Focus

News overview Healthcare & Biotech

Premium selection of analyses, tops and drops to understand the dynamics of the Healthcare & Biotech sector at a glance.

Explore sector Search for a stock

Healthcare & Biotech

Wellgistics Eyes $105M Acquisition

Wellgistics Health has signed a non-binding letter of intent to explore the acquisition of Neuritek Therapeutics in an all-stock deal valued at $105 million. The target, which specializes in innovative therapies for neurological and psychiatric disorders, would allow the group to expand its healthcare platform and strengthen its presence in specialty care. …

Published today WGRX 0.10 · 1.94 % acquisition• healthcare• external growth

Medline Expands Texas Logistics Network

Medline Inc (NASDAQ: MDLN) announced a major expansion with a new 1.2 million sq ft distribution center in Midlothian, Texas, scheduled to be operational by Q2 2027. This move strengthens Medline's gr...

MDLN 2 weeks ago

44.28 0.64 %

Abivax rocked by AstraZeneca buyout rumors despite denial

At the end of March 2026, Abivax shares reacted to speculation about an exclusivity period granted to AstraZeneca for a possible takeover bid. However, Abivax's official denial cooled enthusiasm, main...

ABVX 3 weeks ago

101.40 0.59 %

Ralliant Posts Strong Growth Despite Barclays Cut

Ralliant Corporation reported a 1% revenue increase in Q4 2025, surpassing expectations thanks to a robust 29% growth in its Communications segment. Despite this strong performance, Barclays lowered i...

RAL 1 month ago

42.00 1.41 %

Hinge Health Lowers Targets but Upside Potential Stays

Hinge Health (NYSE: HNGE) has seen its price targets cut by several analysts, with KeyBanc lowering its target from $70 to $55 while maintaining an "overweight" rating. Similarly, Evercore ISI trimmed...

HNGE 1 month ago

39.26 2.24 %

Continuous feed

The latest updates, in real time.

20 updates

Sanofi faces Dupixent patent expiry in 2031

Healthcare & Biotech SAN

82.58 0.35 %

Sanofi Completes Acquisition of Dynavax

Healthcare & Biotech SAN

82.58 0.35 %

Sanofi Boosts Profitability with Dupixent Despite Stock Drop

Healthcare & Biotech SAN

82.58 0.35 %

J.P. Morgan Chase Exceeds 10% Stake in DBV Technologies

Healthcare & Biotech DBV

3.63 3.07 %

CARMAT Enters Judicial Recovery, Seeks Investors

Healthcare & Biotech ALCAR

0.10 –

Abivax falls as buyout hopes fade

Healthcare & Biotech ABVX

101.40 0.59 %

Ikonisys Raises €2.72M via Capital Raise and Debt Conversion

Healthcare & Biotech ALIKO

1.52 –

Genfit Reports Q3 2025 Results, Exits US Nasdaq

Healthcare & Biotech GNFT

6.27 1.29 %

Oncodesign Ends Collaboration with Navigo Proteins

Healthcare & Biotech ALOPM

0.48 1.68 %

GenSight Biologics Strengthens Funding and Regulatory Status

Healthcare & Biotech SIGHT

0.09 2.08 %

ProShares RXL announces share buybacks in August 2025

Healthcare & Biotech RXL

45.94 1.52 %

Valneva Restructures, Regains Control of Chikungunya Vaccine

Healthcare & Biotech VLA

2.71 3.97 %

Nanobiotix Joins CAC Mid 60 and SBF 120 on Euronext Paris

Healthcare & Biotech NANO

27.40 5.35 %

Insider Sell-Off at Sionna Therapeutics Raises Concerns

Healthcare & Biotech SION

40.49 1.96 %

NicOx boosts cash and plans NCX 470 filing in 2026

Healthcare & Biotech ALCOX

0.41 0.49 %

Sanofi to acquire Dynavax for $2.2 billion

Healthcare & Biotech DVAX

15.50 0.06 %

WORK Medical announces 1-for-100 stock consolidation

Healthcare & Biotech WOK

1.20 2.56 %

Abivax Draws Big Pharma Interest on Promising Data

Healthcare & Biotech ABVX

101.40 0.59 %

Medincell posts strong H1 results, preps Olanzapine LAI launch

Healthcare & Biotech MEDCL

23.10 0.69 %

Bayer rallies on restructuring and medical advances

Healthcare & Biotech BAYN

38.38 0.21 %